Rights and permissions
About this article
Cite this article
Etanercept considered cost effective vs DMARDs in RA. Pharmacoecon. Outcomes News 446, 5 (2004). https://doi.org/10.2165/00151234-200404460-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404460-00012